286 related articles for article (PubMed ID: 26230099)
1. Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile Infection.
Leber A; Viladomiu M; Hontecillas R; Abedi V; Philipson C; Hoops S; Howard B; Bassaganya-Riera J
PLoS One; 2015; 10(7):e0134849. PubMed ID: 26230099
[TBL] [Abstract][Full Text] [Related]
2. The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity.
Leslie JL; Vendrov KC; Jenior ML; Young VB
mSphere; 2019 Jan; 4(1):. PubMed ID: 30700514
[No Abstract] [Full Text] [Related]
3. Infection With
Schmidt CJ; Wenndorf K; Ebbers M; Volzke J; Müller M; Strübing J; Kriebel K; Kneitz S; Kreikemeyer B; Müller-Hilke B
Front Immunol; 2020; 11():571049. PubMed ID: 33193352
[TBL] [Abstract][Full Text] [Related]
4. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.
Buffie CG; Jarchum I; Equinda M; Lipuma L; Gobourne A; Viale A; Ubeda C; Xavier J; Pamer EG
Infect Immun; 2012 Jan; 80(1):62-73. PubMed ID: 22006564
[TBL] [Abstract][Full Text] [Related]
5. The Butyrate-Producing Bacterium
Hayashi A; Nagao-Kitamoto H; Kitamoto S; Kim CH; Kamada N
J Immunol; 2021 Apr; 206(7):1576-1585. PubMed ID: 33597149
[TBL] [Abstract][Full Text] [Related]
6. An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile.
Miezeiewski M; Schnaufer T; Muravsky M; Wang S; Caro-Aguilar I; Secore S; Thiriot DS; Hsu C; Rogers I; DeSantis T; Kuczynski J; Probst AJ; Chehoud C; Steger R; Warrington J; Bodmer JL; Heinrichs JH
ISME J; 2015 Feb; 9(2):321-32. PubMed ID: 25036923
[TBL] [Abstract][Full Text] [Related]
7. Response of the gut microbiota during the Clostridioides difficile infection in tree shrews mimics those in humans.
Gu W; Li W; Wang W; Kuang D; Zhang W; Lu C; Li N; Tong P; Han Y; Sun X; Lu J; Wu Y; Dai J
BMC Microbiol; 2020 Aug; 20(1):260. PubMed ID: 32819295
[TBL] [Abstract][Full Text] [Related]
8. Modeling the role of peroxisome proliferator-activated receptor γ and microRNA-146 in mucosal immune responses to Clostridium difficile.
Viladomiu M; Hontecillas R; Pedragosa M; Carbo A; Hoops S; Michalak P; Michalak K; Guerrant RL; Roche JK; Warren CA; Bassaganya-Riera J
PLoS One; 2012; 7(10):e47525. PubMed ID: 23071818
[TBL] [Abstract][Full Text] [Related]
9. Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria.
Passmore IJ; Letertre MPM; Preston MD; Bianconi I; Harrison MA; Nasher F; Kaur H; Hong HA; Baines SD; Cutting SM; Swann JR; Wren BW; Dawson LF
PLoS Pathog; 2018 Sep; 14(9):e1007191. PubMed ID: 30208103
[TBL] [Abstract][Full Text] [Related]
10. Integrating gut microbiome and host immune markers to understand the pathogenesis of
Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
[No Abstract] [Full Text] [Related]
11. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.
Lamont JT
Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708
[TBL] [Abstract][Full Text] [Related]
12. Recent insights into Clostridium difficile pathogenesis.
Peniche AG; Savidge TC; Dann SM
Curr Opin Infect Dis; 2013 Oct; 26(5):447-53. PubMed ID: 23982235
[TBL] [Abstract][Full Text] [Related]
13. Microbe-microbe interactions during Clostridioides difficile infection.
Abbas A; Zackular JP
Curr Opin Microbiol; 2020 Feb; 53():19-25. PubMed ID: 32088581
[TBL] [Abstract][Full Text] [Related]
14. The role of zinc and nutritional immunity in Clostridium difficile infection.
Zackular JP; Skaar EP
Gut Microbes; 2018; 9(5):469-476. PubMed ID: 29533126
[TBL] [Abstract][Full Text] [Related]
15. Role of microbiota and innate immunity in recurrent Clostridium difficile infection.
Bibbò S; Lopetuso LR; Ianiro G; Di Rienzo T; Gasbarrini A; Cammarota G
J Immunol Res; 2014; 2014():462740. PubMed ID: 24995345
[TBL] [Abstract][Full Text] [Related]
16. Strain-Dependent Inhibition of Clostridioides difficile by Commensal
Reed AD; Nethery MA; Stewart A; Barrangou R; Theriot CM
J Bacteriol; 2020 May; 202(11):. PubMed ID: 32179626
[No Abstract] [Full Text] [Related]
17. Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice.
Sadighi Akha AA; McDermott AJ; Theriot CM; Carlson PE; Frank CR; McDonald RA; Falkowski NR; Bergin IL; Young VB; Huffnagle GB
Immunology; 2015 Apr; 144(4):587-97. PubMed ID: 25327211
[TBL] [Abstract][Full Text] [Related]
18. Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection.
Normington C; Moura IB; Bryant JA; Ewin DJ; Clark EV; Kettle MJ; Harris HC; Spittal W; Davis G; Henn MR; Ford CB; Wilcox MH; Buckley AM
NPJ Biofilms Microbiomes; 2021 Feb; 7(1):16. PubMed ID: 33547298
[TBL] [Abstract][Full Text] [Related]
19. Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome.
Steinway SN; Biggs MB; Loughran TP; Papin JA; Albert R
PLoS Comput Biol; 2015 May; 11(5):e1004338. PubMed ID: 26102287
[TBL] [Abstract][Full Text] [Related]
20. Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection.
Littmann ER; Lee JJ; Denny JE; Alam Z; Maslanka JR; Zarin I; Matsuda R; Carter RA; Susac B; Saffern MS; Fett B; Mattei LM; Bittinger K; Abt MC
Nat Commun; 2021 Feb; 12(1):755. PubMed ID: 33531483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
